West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 100,200 | 91,800 | 119,200 | 110,400 | 94,600 |
| Marketable Securities | 26,400 | 26,500 | N/A | N/A | N/A |
| Receivables | 176,000 | 147,200 | 153,100 | 165,700 | 161,200 |
| Inventories | 158,200 | 151,800 | 155,500 | 161,200 | 157,100 |
| Income taxes - deferred | 7,500 | 7,900 | 10,700 | 11,500 | 11,300 |
| Other current assets | 34,500 | 46,800 | 65,000 | 61,600 | 56,900 |
| TOTAL | $502,800 | $472,000 | $503,500 | $510,400 | $481,100 |
| Non-Current Assets | |||||
| PPE Net | 619,200 | 593,600 | 576,100 | 581,500 | 574,500 |
| Investments And Advances | 58,300 | 56,200 | 55,000 | 51,200 | 48,900 |
| Intangibles | 163,900 | 163,500 | 166,200 | 170,300 | 170,300 |
| Other Non-Current Assets | 113,100 | 113,800 | 97,500 | 101,900 | 91,300 |
| TOTAL | $954,500 | $927,100 | $894,800 | $904,900 | $885,000 |
| Total Assets | $1,457,300 | $1,399,100 | $1,398,300 | $1,415,300 | $1,366,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 82,700 | 89,800 | 71,700 | 73,400 | 66,200 |
| Accrued Expenses | 37,100 | 45,000 | 48,500 | 48,200 | 48,600 |
| Other current liabilities | 71,500 | 41,000 | 34,700 | 45,400 | 43,000 |
| TOTAL | $302,400 | $243,200 | $229,300 | $192,700 | $182,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 294,900 | 299,300 | 323,300 | 367,200 | 364,700 |
| aiOther Non-Current Liabilities | 144,700 | 180,100 | 134,600 | 138,300 | 134,500 |
| TOTAL | $460,200 | $501,000 | $477,700 | $526,600 | $520,200 |
| Total Liabilities | $762,600 | $744,200 | $707,000 | $719,300 | $703,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,749 | 67,559 | 67,433 | 67,346 | 66,976 |
| Common Shares | 8,600 | 8,600 | 8,600 | 8,600 | 8,600 |
| Retained earnings | 687,600 | 664,500 | 657,800 | 641,200 | 626,700 |
| Other shareholders' equity | -58,800 | -71,500 | -24,100 | -400 | -10,300 |
| TOTAL | $694,700 | $654,900 | $691,300 | $696,000 | $663,100 |
| Total Liabilities And Equity | $1,457,300 | $1,399,100 | $1,398,300 | $1,415,300 | $1,366,100 |